🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This is a Phase 1, double-blind (Sponsor-open), placebo-controlled, randomi...
Status
Completed
Location
High Point Clinical Trials Center
Start Date
2022-07-07
Trial ID
NCT05462132
Treatments Being Tested
The purpose of this study was to evaluate safety and efficacy of the combin...
Status
Terminated
Location
California Cancer Associates for Research and Excellence
Start Date
2017-02-17
Trial ID
NCT02967692
Treatments Being Tested
The primary objective of the current study is to investigate the safety and...
Status
Completed
Location
1289.1.1 Boehringer Ingelheim Investigational Site
Start Date
2011-04-01
Trial ID
NCT01343706
Subdural hematoma (SDH) is a common condition experienced after head injury...
Status
Recruiting
Location
St. Michael's Hospital
Start Date
2026-05-20
Trial ID
NCT05713630
Treatments Being Tested
This is a randomized, placebo-controlled, 2-part, sequential, single ascend...
Status
Completed
Location
Celerion
Start Date
2011-04
Trial ID
NCT01862939
This is a randomized, double-blind, placebo-controlled, multiple ascending ...
Status
Completed
Location
Division of Clinical Pharmacology, Centre Hospitalier Universitaire Vaudois (CHUV)
Start Date
2019-02-21
Trial ID
NCT03776500
Primary Objective: To evaluate the efficacy of dupilumab administered ever...
Status
Completed
Location
Cullman Research Center, LLC Site Number : 8400095
Start Date
2020-07-06
Trial ID
NCT04456673
The primary objective of this study was to evaluate the effect of GLPG3970 ...
Status
Completed
Location
Arensia Exploratory Medicine LLC
Start Date
2020-10-05
Trial ID
NCT04577794
GR181413A/AT1001 (migalastat hydrochloride) is a low molecular weight imino...
Status
Completed
Location
GSK Investigational Site
Start Date
2011-09
Trial ID
NCT01853852
Treatments Being Tested
The purpose of this study is to determine the safety and tolerability of SR...
Status
Completed
Location
GSK Investigational Site
Start Date
2008-05
Trial ID
NCT00933530